---
title: "Definition and epidemiology of systemic sclerosis and scleroderma disorders"
slug: "definition-and-epidemiology-of-systemic-sclerosis-and-scleroderma-disorders"
date: "2023-08-05"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[systemic sclerosis and scleroderma disorders]]

# Definition and epidemiology of systemic sclerosis and scleroderma disorders

- Scleroderma refers to the presence of tight, thickened skin
- Localized scleroderma: morphea (plaques of fibrotic skin), linear (fibrotic bands), â€œen coup de sabreâ€ (linear scleroderma on one side of scalp and forehead â‰ˆ saber scar)
- Systemic sclerosis (SSc) = scleroderma + internal organ involvement. High-mortality.
  - SSc w/ limited cutaneous disease (lcSSc): formerly CREST syndrome (see below)
  - SSc w/ diffuse cutaneous disease (dcSSc): often rapidly progressive skin thickening
  - SSc sine scleroderma (visceral disease without skin involvement, rare)
- Peak onset age 30-50; â™€ >â™‚ (8:1). Earlier/more severe disease in African Americans
- <6/100,000 annual SSc incidence wordwide; lcSSc incidence ~2Ã— that of dcSSc
- Pathogenesis: unclear. Endothelial injury â†’ ROS/oxidative stress â†’ perivascular inflammation â†’ fibrosis. Cytokines, growth factors, genetics, environ. factors + antibodies (against PDGFR, endo. cells, fibroblasts) may contribute (NEJM 2009;360:1989).
